TinaHashiRN said:Dr.KarenChen said: ...regarding the discontinuation data for cost and coverage...
This is exactly what I could not find anywhere else.
Clinical perspective, offered as context rather than as advice.
Telehealth prescriber review for cost and coverage: I've used 3 different telehealth platforms to get my GLP-1 prescription. Comparison:
| Feature | Platform A | Platform B | Platform C |
|---|---|---|---|
| Initial Consult | $64 | $84 | $0 |
| Monthly Follow-up | $34 | Included | $49 |
| Prescription Speed | Same day | 24-48 hours | Same day |
| Lab Monitoring | Required | Optional | Required |
I settled on the one that required labs — it shows they care about safety, not just prescribing volume.
TrialNerd_Beth said:Financial impact of cost and coverage weight loss beyond medication cost: Groceries: SAVED $252/month (eating less) Restaurants: SAVED $222/month…
Insurance update relevant to cost and coverage: I just got my prior auth approved through Anthem after 4 attempts.
What finally worked: a letter from my endocrinologist documenting BMI history (>3 years), failed diet attempts, comorbidities (NAFLD + metabolic syndrome), and referencing the SURMOUNT trial data.
If your PA keeps getting denied, don't give up. Request a peer-to-peer review between your doctor and the insurance medical director. That's what finally broke through for me.
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsDr.GastroMayo said:Denials are usually procedural rather than clinical, and the order that works reflects that.
My insurance denied my PA related to cost and coverage. Has anyone successfully appealed? I'm considering going compounded instead.
Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful.